1. Home
  2. LFTO vs BLLN Comparison

LFTO vs BLLN Comparison

Compare LFTO & BLLN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Liftoff Mobile Inc. Common Stock

LFTO

Liftoff Mobile Inc. Common Stock

N/A

Current Price

$22.76

Market Cap

3.8B

Sector

Technology

ML Signal

N/A

Logo BillionToOne Inc.

BLLN

BillionToOne Inc.

N/A

Current Price

$127.00

Market Cap

5.8B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
LFTO
BLLN
Founded
N/A
2016
Country
United States
United States
Employees
N/A
713
Industry
EDP Services
Medical Specialities
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.8B
5.8B
IPO Year
2026
N/A

Fundamental Metrics

Financial Performance
Metric
LFTO
BLLN
Price
$22.76
$127.00
Analyst Decision
Buy
Analyst Count
0
7
Target Price
N/A
$126.71
AVG Volume (30 Days)
671.9K
594.9K
Earning Date
N/A
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$46.29
Revenue Next Year
N/A
$30.14
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$21.50
$61.96
52 Week High
$27.94
$138.70

Technical Indicators

Market Signals
Indicator
LFTO
BLLN
Relative Strength Index (RSI) 45.24 58.49
Support Level $21.77 $79.07
Resistance Level $25.96 $138.70
Average True Range (ATR) 1.46 7.25
MACD -0.10 -0.92
Stochastic Oscillator 29.68 70.21

Price Performance

Historical Comparison
LFTO
BLLN

About LFTO Liftoff Mobile Inc. Common Stock

Liftoff Mobile Inc is a marketing and retargeting platform that helps businesses maximize revenue through machine learning-powered solutions. Its AI-powered platform is designed to serve all verticals in the app ecosystem and is fully integrated to drive differentiated advertising performance for its customers across the app economy. The company deliver profitable users for app advertisers and help to maximize advertising revenue for apps that monetize with ads. Its solutions include: Marketers; Agencies; DSPs; Publishers; and Mobile Gaming.

About BLLN BillionToOne Inc.

BillionToOne Inc is a molecular diagnostics company. It offers a portfolio of ultrasensitive tests covering prenatal genetic testing, cancer therapy selection, and response monitoring, which are based on its Quantitative Counting Templates (QCT) molecular counting platform. The company's product portfolio comprises UNITY, a portfolio of prenatal testing products that can conduct fetal risk analysis without requiring a paternal sample; Northstar Select, a ultrasensitive liquid biopsy test that provides insights into appropriate therapies for stage III or IV cancer patients; and Northstar Response, a tissue-free, pan-cancer, liquid biopsy test that measures several genomic loci uniquely methylated in cancer to provide insight into dynamic changes in therapy response.

Share on Social Networks: